Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)(†)

BACKGROUND: This was a post hoc analysis of patients with non-squamous histology from a phase III maintenance pemetrexed study in advanced non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: The six symptom items' [average symptom burden index (ASBI)] mean at baseline was calculated using...

Descripción completa

Detalles Bibliográficos
Autores principales: Obasaju, C., Bowman, L., Wang, P., Shen, W., Winfree, K. B., Smyth, E. N., Boye, M. E., John, W., Brodowicz, T., Belani, C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660084/
https://www.ncbi.nlm.nih.gov/pubmed/23559150
http://dx.doi.org/10.1093/annonc/mdt123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660084/
https://www.ncbi.nlm.nih.gov/pubmed/23559150
http://dx.doi.org/10.1093/annonc/mdt123

Ejemplares similares